Sign up to save your podcasts
Or
Share Why Does PrEP Use Lag in Cisgender Women?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Why Does PrEP Use Lag in Cisgender Women?
How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more. Related Content:
- HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
View all episodes
By JAMA Network
4.6
162162 ratings
How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more. Related Content:
- HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
More shows like Healthy Dialogue
View all
Fresh Air
38,430 Listeners
Hidden Brain
43,687 Listeners
The Moth
27,011 Listeners
JAMA Editors' Summary
134 Listeners
NEJM This Week
321 Listeners
Emergency Medicine Cases
549 Listeners
AFP: American Family Physician Podcast
701 Listeners
JAMA Clinical Reviews
504 Listeners
Science Friday
6,467 Listeners
Mayo Clinic Talks
298 Listeners
Frankly Speaking About Family Medicine
264 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
JAMA Psychiatry Author Interviews
21 Listeners
JAMA Neurology Author Interviews
16 Listeners
JAMA Cardiology Author Interviews
8 Listeners
JAMA Surgery Author Interviews
7 Listeners
JAMA Internal Medicine Author Interviews
19 Listeners
JAMAevidence The Rational Clinical Examination
31 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
518 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
The Curious Clinicians
375 Listeners